For a PDF version of the Programme Timetable: Saturday, Sunday, Monday, Tuesday
The EPA 2012 Scientific Programme will be composed of five main tracks:
Research Track – will compose of sessions with a focus on current research trends in psychiatry. Among the Research Track you will find Symposia, Debates, and State of the Art sessions.
Clinical / Therapeutic Track –will offer participants updated, state of the art, clinical and therapeutic information which is based on research but linked to daily practice. Among the Clinical /Therapeutic Track you will find Symposia, Updates, Debates and Workshop session
Education Track – the sessions in this track will provide an update on developments in the field and provide an opportunity for exchanges of ideas between participants and speakers. Among the Educational Track, you will find the CME Academia Courses and Update Sessions.
European Track - the sessions in this track will deal with common issues for psychiatrists from across Europe, and will therefore be of particular interest for members of the National Psychiatric Associations.
ECP Education Track – the sessions in this Track are the sessions of the Early Career Psychiatrists’ Programme.
**Programme is subject to minor changes
Plenary Sessions
The Plenary Lectures have a strong scientific focus and are mainly theoretical and research-oriented. These lectures will be delivered by leading psychiatrists, basic scientists and other mental health professionals invited by the Scientific Committee. These 45 minute lectures, will cover the major topics of the Congress theme.
|
Genetics of ADHD
Philip Asherson, UK |
|
Individualised Therapy of Alcoholism
Karl Mann, Germany |
|
The Human Brain Project - A New Paradigm for Modeling Brain Function and Dysfunction
Richard Frackowiak, Switzerland |
State of the Art Lectures
The state-of-the-art lectures provide a complete update on significant aspects of current clinical treatments in European psychiatry will be delivered by top European or worldwide experts and will last 45 minutes.
|
The Role of Biomarkers in Psychiatry
Andreas Meyer-Lindenberg, Germany |
|
Alzheimer’s Disease
Philippe Robert, France |
|
Deep Brain Stimulation in Psychiatry
Luc Mallet, France |
|
Understanding and Treating Depression
Siegfried Kasper, Austria |
|
Progress in Understanding and Treating Addiction
Wim van den Brink, The Netherlands |
|
Update on Pathophysiology of Schizophrenia
Peter Falkai, Germany |
Pro & Con Debates
Debates will be offer a lively and fruitful discussion on controversial issues. A chairperson will moderate whilst two speakers (one pro and the other con) will offer and challenge opinions on different subjects.
|
Polypharmacy is Necessary in Psychiatry
Pro: Hans-Jürgen Möller, Germany
Con: Speaker to be Announced |
|
Haloperidol is the Best Ever
Pro: RH Belmaker, Israel
Con: René Kahn, The Netherlands |
|
The Concept of Mental Health is Misleading
Pro: Mary Baker, UK
Con: Matt Muijen, Denmark
|
Core Symposia
The Core Symposia focus on clinical issues and constitute the central element of the Congress. There will be 7 Core Symposia scheduled as part of the programme.
|
Chair: Henning Sass, Germany
Co-Chair: Norman Sartorius, Switzerland |
|
Introduction to Comorbidity between Mental and Physical Disorders
Norman Sartorius, Switzerland |
Mental Disorders and Diabetes
Norbert Hermanns, Germany |
Mental Disorders and Cancer
Christoph Lauber, UK |
Chair: Siegfried Kasper, Austria
Co-Chair: Michael Bauer, Germany |
European Program for TRD
Siegfried Kasper, Austria |
Augmentation Strategies in TRD
Michael Bauer, Germany |
Brain Stimulation in TRD
Frank Padberg, Germany |
|
Chair: Marianne Kastrup, Denmark
Co-Chair: Henning Sass, Germany |
Personality Disorders and Dissocial Behaviours: Forensic Consequences of Diagnostic Concepts
Henning Sass, Germany |
|
Conflict of Interest in Psychiatry
Cyril Höschl, Czech Republic |
Ethical Issues and Training in Psychiatry
Cécile Hanon, France |
Chair: Silvana Galderisi, Italy
Co-Chair: Sopia Frangou, UK |
Competence Risk and Resilience in Development
Oddgeir Friborg, Norway |
Resilience to Adult Psychopathology Following Childhood Maltreatment
Barbara Maughan, UK |
Genetic Underpinning of Resilience
Peter Lesch Klaus, Germany |
Chair: Moshe Szyf, Canada
Co-Chair: Philip Gorwood, France |
Environmental Epigenomics in Psychiatry
Moshe Szyf, Canada |
The Epigenetic of Psychosis
|
Long Term Effects After a Single Event: PTSD as an Example of Epigenetic Impact?
Elisabeth Binder, Germany |
| Chair: István Bitter, Hungary |
From Psychoanalysis to Modern Pharmacotherapy
Jules Angst, Switzerland |
Combining psychotherapy and drug treatment: does it change the process of psychotherapy?
Horst Kächele, Germany |
Combined Treatment is More Effective than Psychotherapy or Pharmacotherapy Alone. Is the Difference Relevant for the Practice?
Pim Cuijpers, The Netherlands |
Chair: Philip Asherson, UK
Co-Chair: Janet Treasure, UK |
Starving Instead of Eating as a Reward: The Case of Anorexia Nervosa
Anne-Katherina Fladung, Germany |
Oily Fish and Omega-3 Fatty Acids: What is the Effect Size?
Maria Makrides, Australia |
|
Avoiding Food Allergy Reduces ADHD… Should We Change Our Prescriptions?
Rob Rodrigues Pereira, The Netherlands |
EUROPEAN fORUM
The European Forum will be split into 2 parts, and will provide a scientific setting for the exchange of information and experiences between the various National Psychiatric Associations
Chair: Patrice Boyer, France
Co-Chair: Mariano Bassi, Italy |
The Role of the Psychiatrist in the Border Areas
Manuel Martin Carrasco, Spain |
Transitions: the Role of the Psychiatrist in the Different Stages of Life
Dinesh Bhugra,UK |
| Standards of Training in Europe |
Chair: Patrice Boyer, France
Co-Chair: Mariano Bassi, Italy |
Migration of Psychiatrists in Europe, from a Central-Eastern European Perspective, Including New Member States of the EU
Tamás Kurimay, Hungary |
Can recovery be a realistic goal to be attained for patients affected by psychotic disorders? An italian view
Bernardo Carpiniello, Italy |
Mental Health Promotion : Conceptual review and Practice in Europe
George Christodoulou, Greece |
* As of November 2011.
**Hall Allocation Subject to Change